Today: 29 June 2026
Browse Category

NASDAQ:OLMA 18 November 2025 - 29 January 2026

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

NEW YORK, Dec. 28, 2025, 6:44 a.m. ET — Market closed Olema Pharmaceuticals, Inc. heads into the final trading days of 2025 with investors trying to separate two very different realities: an explosive year-to-date run that put the breast-cancer biotech firmly on the growth-stock map—and a sharp late-December pullback that has reset near-term expectations.
28 December 2025
··
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

NEW YORK, Dec. 27, 2025, 8:26 PM ET — Market closed Olema Pharmaceuticals, Inc. is heading into the weekend with investors weighing a sharp Friday pullback against a still-staggering multi-month run, a cluster of insider-trading filings, and a set of analyst price targets that continue to imply significant upside—if Olema’s late-stage breast cancer program delivers on its timeline.
28 December 2025
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals, Inc. trades under the ticker OLMA on Nasdaq. GlobeNewswire+1 On Friday, December 19, 2025, the stock was sharply lower intraday—$28.89, down $1.92 at the latest published trade time in the market data feed, after opening $31.22 and swinging between $31.95 and $28.89. That kind of whiplash has become the defining feature of OLMA lately: it’s a clinical-stage oncology name where headline risk and financing mechanics can move the stock fast.
19 December 2025
···
Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the middle of a high-stakes bet on a single breast-cancer drug. Below is a structured look at OLMA stock today, the latest news, Street forecasts, and the key risks investors are debating as of December 9, 2025.
9 December 2025
··

Stock Market Today

  • Ross Stores (NASDAQ:ROST) tops Q1 estimates, outpaces discount peers on revenue
    June 29, 2026, 3:43 PM EDT. Ross Stores (NASDAQ:ROST) pulled in $6.01 billion in revenue for Q1, up 20.6% from a year ago and 6.6% over forecasts, leading discount retail. The off-price chain kept customer traffic strong with sales of excess inventory at deep discounts. CEO Jim Conroy pointed to good execution, marketing, and a boost from tax refund spending. Still, shares of discount retailers dropped about 4.5% after earnings, as investors weighed worries around e-commerce and lower mall traffic. Ross stays focused on its value model as retail faces mixed signals.
Go toTop